PROM1 and hepatocellular carcinoma: Given the strong rationale linking CD133 expression to more aggressive cellular behavior, including resistance to chemotherapy and radiotherapy, a direct correlation between CD133 expression and advanced disease stage as well as poor differentiation grade has been shown in hepatocellular carcinoma [17].